Kevin Mizell, MS

Kevin Mizell, MS has held various roles in the clinical research field since 2008. Kevin began their career as a Clinical Research Coordinator & Research Manager at Southeastern Research Associates, Inc. & AnMed. In 2013, they moved on to become an Early & Late Phase Solid Tumor Oncology Research Manager at Medical University of South Carolina. In 2014, they became a CRA I at PPD. Kevin then moved on to become a CRA II and CRA I at Covance in 2015. In 2018, they took on the role of Sr. CRA/Clinical Trial Lead at Pharm-Olam, LLC. In 2019, they worked as a Sr. CRA at Avanir Pharmaceuticals, UroGen Pharma, and Vibrant Gastro. Kevin also worked as an Independent Consultant at Palmetto Clinical Trials Consulting, LLC. Currently, they are employed at Imvax, Inc. as a Clinical Oversight Lead, Clinical Trial Lead, and Sr. CRA.

Kevin Mizell, MS received their Bachelor's degree in BA from Clemson University in 1999. Kevin then went on to Southern Wesleyan University and completed their Master of Science - MSM in 2003.